Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: Letter to the Editor
Restricted accessLetterFirst published online October, 2019
Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: Letter to the Editor
KvittingJPEOlinCL. Clarence Crafoord: a giant in cardiothoracic surgery, the first to repair aortic coarctation. Ann Thorac Surg. 2009;87(1):342-346.
2.
LiberatiAAltmanDGTetzlaffJ, etal. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-e34.
3.
MuradMHMontoriVMIoannidisJPA, etal. How to read a systematic review and meta-analysis and apply the results to patient care: users’ guides to the medical literature. JAMA. 2014;312(2):171-179.
4.
MurrayG. Anticoagulant therapy with heparin. Am J Med. 1947;3(4):468-471.
5.
RothP. Prophylaxis of deep vein thrombosis in outpatients undergoing arthroscopic meniscus operation. Orthop Praxis. 1995;5:345-348.
6.
SobierajDColemanCITongbramV, etal. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis. Pharmacotherapy. 2012;32(9):799-808.
7.
ZhuJJiangHMarshallBLiJTangX.Low-molecular-weight heparin for the prevention of venous thromboembolism in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction: a meta-analysis of randomized controlled trials. Am J Sports Med. 2019;47(8):1994-2002.
